Sensitivity: 0.1ng/mL
Size: 96T Price: $420
Size: 48T Price: $336
KEY FEATURES
| Full Name | Matrix Metalloproteinase 9 |
|---|---|
| Synonym | MMP9;CLG4B;Gelatinase B;GELB;MANDP2;92kDa Type IV Collagenase;92 KDa Gelatinase; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.16-10ng/mL |
| Sensitivity | 0.1ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human MMP-9 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human MMP-9. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human MMP-9 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human MMP-9, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human MMP-9. You can calculate the concentration of Human MMP-9 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Human MMP-9 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.55 | 1.45 | 4.74 | 0.51 | 1.31 | 4.58 |
| Standard deviation | 0.04 | 0.08 | 0.19 | 0.03 | 0.07 | 0.17 |
| CV(%) | 6.75 | 5.76 | 4.1 | 6.14 | 5.65 | 3.7 |
RECOVERY
The recovery of Human MMP-9 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 85-97 | 90 |
| EDTA plasma (n=8) | 92-106 | 97 |
| Cell culture media (n=8) | 91-102 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human MMP-9 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Products associated with Lcn2 ELISA Kits
| Mmp9 antibody | publications with Lcn2 and Mmp9 |
| Hmox1 antibody | publications with Lcn2 and Hmox1 |
| Erbb2 antibody | publications with Lcn2 and Erbb2 |
| Vegfa antibody | publications with Lcn2 and Vegfa |
| Il17a antibody | publications with Lcn2 and Il17a |
| Cdh1 antibody | publications with Lcn2 and Cdh1 |
| Lep antibody | publications with Lcn2 and Lep |
| Vegp1 antibody | publications with Lcn2 and Vegp1 |
Pathways associated with Lcn2 ELISA Kit
| Iron Uptake And Transport Pathway | Iron Uptake And Transport Pathway |
| Transmembrane Transport Of Small Molecules Pathway | Transmembrane Transport Of Small Molecules Pathway |
Diseases associated with Lcn2 ELISA Kit
| Kidney Diseases | publications with Lcn2 and Kidney Diseases |
| Acute Kidney Injury | publications with Lcn2 and Acute Kidney Injury |
| Renal Insufficiency | publications with Lcn2 and Renal Insufficiency |
| Inflammation | publications with Lcn2 and Inflammation |
| Cardiovascular Diseases | publications with Lcn2 and Cardiovascular Diseases |
| Heart Diseases | publications with Lcn2 and Heart Diseases |
| Necrosis | publications with Lcn2 and Necrosis |
| Proteinuria | publications with Lcn2 and Proteinuria |
| Disease Models, Animal | publications with Lcn2 and Disease Models, Animal |
| Renal Insufficiency, Chronic | publications with Lcn2 and Renal Insufficiency, Chronic |
Organs/Tissues associated with Lcn2 ELISA Kit
| Liver | publications with Lcn2 and Liver |
| Heart | publications with Lcn2 and Heart |
| Lung | publications with Lcn2 and Lung |
| Connective Tissue | publications with Lcn2 and Connective Tissue |
| Pancreas | publications with Lcn2 and Pancreas |
| Eye | publications with Lcn2 and Eye |
| Spleen | publications with Lcn2 and Spleen |
| Ovary | publications with Lcn2 and Ovary |
| Cervix | publications with Lcn2 and Cervix |
| Uncharacterized Tissue | publications with Lcn2 and Uncharacterized Tissue |